The INFORM Study: Rotational Fractional Resection for Submental Contouring
NCT03853980 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2020-03-06
Summary
Efficacy and safety of Rotational Fractional Resection (skin resection) in patients with moderate to severe submental skin laxity.
Conditions
- Skin Laxity
Interventions
- DEVICE
-
Focal Contouring System
Single treatment of skin resection (removal of loose skin)
Sponsors & Collaborators
-
Recros Medica, Inc.
lead INDUSTRY
Principal Investigators
-
Robin McIntosh · Recros Medica
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-18
- Primary Completion
- 2020-10-31
- Completion
- 2020-10-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
ET-01 in Subjects With Lateral Canthal Lines, LCL-207
NCT03655691 ·Status: COMPLETED ·Phase: PHASE2
-
Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation
NCT05929625 ·Status: COMPLETED ·Phase: NA
-
Lutronic Infini and LaseMD Systems in Combination Treatment
NCT03409965 ·Status: COMPLETED ·Phase: NA
-
Fractional CO2 Laser System (Fraxel Repair Laser) Intended for Treatment of Perioral Rhytides/Wrinkles
NCT03715049 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum
NCT04795622 ·Status: COMPLETED ·Phase: NA
-
Sculptra for Décolletage Crepiness and Wrinkling
NCT03508973 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling
NCT05525026 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00968942 ·Status: COMPLETED ·Phase: PHASE2
-
Laser-assisted Hyaluronic Acid Delivery by Fractional CO2 Laser in Facial Skin Remodeling
NCT03979586 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
NCT01519934 ·Status: COMPLETED
-
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation
NCT05987917 ·Status: COMPLETED ·Phase: NA
-
Lutronic Genius System for Neck Treatment
NCT03534609 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles
NCT01566396 ·Status: COMPLETED ·Phase: NA
-
Comparison of an Office-based Limited Facelift and Hospital-based Full Facelift
NCT05419609 ·Status: UNKNOWN ·Phase: NA
-
A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines
NCT02626598 ·Status: UNKNOWN
-
Microbotox for Lower Face Rejuvenation
NCT03189082 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen
NCT05963204 ·Status: COMPLETED ·Phase: NA
-
A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing
NCT07214272 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lifting and Tightening of the Face and Neck Following an Increased Density Treatment
NCT01519206 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
NCT02580370 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00907387 ·Status: COMPLETED ·Phase: PHASE2
-
Mandible and Sub-mandible Using the 1440nm Wavelength Laser and Hand Piece
NCT01813747 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
NCT00512135 ·Status: COMPLETED ·Phase: PHASE3